KAN.ST
Kancera AB
Price:  
1.49 
SEK
Volume:  
117,334.00
Sweden | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

KAN.ST WACC - Weighted Average Cost of Capital

The WACC of Kancera AB (KAN.ST) is 5.2%.

The Cost of Equity of Kancera AB (KAN.ST) is 6.45%.
The Cost of Debt of Kancera AB (KAN.ST) is 5.00%.

Range Selected
Cost of equity 4.60% - 8.30% 6.45%
Tax rate 20.60% - 20.90% 20.75%
Cost of debt 5.00% - 5.00% 5.00%
WACC 4.3% - 6.1% 5.2%
WACC

KAN.ST WACC calculation

Category Low High
Long-term bond rate 2.5% 3.0%
Equity market risk premium 5.1% 6.1%
Adjusted beta 0.42 0.78
Additional risk adjustments 0.0% 0.5%
Cost of equity 4.60% 8.30%
Tax rate 20.60% 20.90%
Debt/Equity ratio 1 1
Cost of debt 5.00% 5.00%
After-tax WACC 4.3% 6.1%
Selected WACC 5.2%

KAN.ST's CAPM model and how its cost of Equity is calculated

The Cost of Equity reflects the return a company needs to deliver to shareholders to justify the risk of investing in its shares. It’s computed using the Capital Asset Pricing Model (CAPM), which blends the risk-free rate, the stock’s beta, and the market risk premium.

This method evaluates the stock’s risk compared to a safe investment and the market’s overall volatility.

Here’s how we figure out the cost of equity for KAN.ST:

cost_of_equity (6.45%) = risk_free_rate (2.75%) + equity_risk_premium (5.60%) * adjusted_beta (0.42) + risk_adjustments (0.25%)

We include the risk adjustments, which range from 0% to 1%, to keep our WACC conservatives, especially for companies traded in developing markets.